Teleflex acquires Nostix

389

Teleflex has acquired Nostix, a developer of innovative tip confirmation systems that are used to increase the accuracy of vascular access device placement. Currently, Nostix’s electrocardiogram-only system is being marketed in the USA for use in placement of peripherally inserted central catheters and is used as an alternative to X-ray confirmation in adult patients.

“Adding the Nostix product line provides our customers with the ability to implement catheter tip placement solutions that meet their specific therapeutic and budget needs,” said Benson Smith, chairman, president and chief executive officer of Teleflex. “The electrocardiogram-only product and the range of navigation technologies that are under development will complement our Arrow VPS G4 system by diversifying and strengthening our peripherally inserted central catheter tip confirmation and navigation portfolio and enhance our ability to meet customer needs globally. Strategically, the addition of this technology will support Teleflex’s future expansion into tip confirmation for central venous catheters, chronic haemodialysis catheters and ports. We also gain access to an innovative product development pipeline, which includes integrated ultrasound capabilities that will extend our ability to offer differentiated catheter tip positioning solutions well into the future.”

The financial terms of the transaction were not disclosed.